Session: Plenary Oral Abstract Session Title: CID-103, an Anti-CD38 Monoclonal Antibody Demonstrates Decreased RBC Binding and Decreased Interference with Pretransfusion Test Methods Poster Number: P-IG-9 Date/Time: Sunday, Oct. 4 from 1:15-2:15pm ET
CASI Pharmaceuticals © 2024 CASI Pharmaceuticals Inc.
All Rights Reserved.
